Overview

Gender

male

Investor Type

Angel

Investor Stage

Seed

Edward Ludwig has been a Member of the Board of Directors of Boston Scientific since March 2014.

Edward is the former Chairman of the Board of Directors of Becton, Dickinson and Company (“BDX”), a global medical technology company, having served in that position from February 2002 through June 2012.

Edward also served as BDX’s Chief Executive Officer from January 2000 to September 2011 and as its President from May 1999 to December 2008. Edward joined BDX as a Senior Financial Analyst in 1979.

Prior to joining BDX, Edward served as a Senior Auditor with Coopers and Lybrand (now PricewaterhouseCoopers) where he earned his CPA and as a financial and strategic analyst at Kidde, Inc.

Edward serves as Lead Director on Aetna Inc.’s Board of Directors and chairs its Finance Committee and is a Member of the Board of Directors of Xylem, Inc. Edward serves as the Non-Executive Chairman of POCARED, a privately held firm in Israel.

Edward is also a Member of the Board of The Center for Higher Ambition Leadership, which is dedicated to studying, documenting and advancing the principals of Higher Ambition Leadership that drive the most successful enterprises in terms of longer term shared value creation.

Edward served as a Member of the Board of Trustees of the College of the Holy Cross (2005-2013), and the Columbia Business School Board of Overseers (2010-2015). Edward also served as a Member of the Board of Trustees of the Hackensack University Medical Center Network Board of Trustees.

Edward received a B.A. degree in Economics and Accounting from The College of the Holy Cross and a MBA degree from Columbia University.